SBIR PHASE I TOPIC 406: DEVELOPING AVIDENT HEALTH'S MYNAVIGATOR MHEALTH APPLICATION FOR USE IN PATIENT NAVIGATOR BREAST CANCER CARE WORKFLOWS

SBIR 第一阶段主题 406：开发 Avident Health 的 MYNAVIGATOR MHEALTH 应用程序以用于患者导航乳腺癌护理工作流程

• 批准号: 10267368
• 负责人: TAN LU
• 金额: $ 36.13万
• 依托单位: AVIDENT HEALTH, LLC
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-16 至 2021-06-15
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10267368
• 关键词: Anxiety; Back; Breast Cancer Patient; Collaborations; Communication; Data; Development; Electronic Health Record; Evaluation; Family Caregiver; Feedback; Focus Groups; Health; Health care facility; Human; Intellectual Property; Knowledge; Legal patent; Methods; Mobile Health Application; Patient Care Team; Patients; Phase; Research Design; Research Institute; Research Methodology; Review Literature; Small Business Innovation Research Grant; Surveys; Testing; cancer care; design; effectiveness testing; heuristics; improved; malignant breast neoplasm; patient engagement; product development; prototype; software development; technological innovation; tool; usability

Avident Health, in partnership with MedStar Health Research Institute (MHRI), will develop the MyNavigator mHealth App and conduct a usability study for breast cancer Patient Navigators (PNs) and their patients. Objectives: (1) develop an Minimum Viable Product (MVP) that increases PN operational efficiencies, facilitates seamless communications, collaboration, and knowledge transfer between PNs, patients, patients’ families, and caregivers; (2) obtain PN, patient, and clinician feedback, and (3) integrate MyNavigator with Electronic Health Records. Specific Aims: (1) establish feasibility as a tool for PNs, (2) build a human-centered design prototype, and (3) test effectiveness among 25+ users. Research Design & Methods rely on Project Management best practices, establishing a need using the York Method for literature reviews, Agile software development for solution development, and heuristic evaluation for usability. Formative and summative testing will be completed upon MVP development at MedStar Health facilities. Technological Innovation includes leveraging Avident’s existing intellectual property, which is protected by two patent applications, and creating a brand new tool to identify and serve the needs of PNs. Expected results: (1) MyNavigator refined utilizing stakeholder focus groups and validated with survey data and quantitative back-end app data. (2) MyNavigator improves communication and patient engagement while reducing cancer care team patient anxiety.

Avident Health将与MedStar健康研究所（MHRI）合作开发MyNavigator mHealth应用程序，并为乳腺癌患者导航仪（PN）及其患者进行可用性研究。目的：（1）开发最小可行产品（MVP），以提高PN运营效率，促进PN、患者、患者家属和护理人员之间的无缝通信、协作和知识转移;（2）获得PN、患者和临床医生反馈，以及（3）将MyNavigator与电子健康记录集成。具体目标：（1）建立可行性作为工具的PN，（2）建立一个以人为本的设计原型，（3）测试25+用户的有效性。研究设计和方法依赖于项目管理的最佳实践，建立了一个需要使用约克方法进行文献综述，敏捷软件开发的解决方案开发，和启发式评估的可用性。将在MedStar Health机构开发MVP时完成形成性和总结性测试。技术创新包括利用Avident现有的知识产权（受两项专利申请保护），并创建一个全新的工具来识别和满足PN的需求。预期成果：（1）MyNavigator利用利益相关者焦点小组进行了改进，并通过调查数据和定量后端应用程序数据进行了验证。(2)MyNavigator改善了沟通和患者参与度，同时减少了癌症护理团队患者的焦虑。